Viewing Study NCT00646659


Ignite Creation Date: 2025-12-24 @ 3:04 PM
Ignite Modification Date: 2026-02-26 @ 4:16 PM
Study NCT ID: NCT00646659
Status: TERMINATED
Last Update Posted: 2018-07-09
First Post: 2008-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module